Company Fujian Cosunter Pharmaceutical Co., Ltd.

Equities

300436

CNE100001YZ0

Pharmaceuticals

End-of-day quote Shenzhen S.E. 03:30:00 20/06/2024 am IST 5-day change 1st Jan Change
16.05 CNY +0.82% Intraday chart for Fujian Cosunter Pharmaceutical Co., Ltd. -2.01% -37.38%

Business Summary

Fujian Cosunter Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of nucleoside anti-HBV drugs. The Company's major products include Adefovir Dipivoxil Tablets, Lamivudine Tablets, Entecavir Capsules and other nucleoside anti-HBV drugs. The Company also produces over-the-counter (OTC) drugs, such as ferrous fumarate and ganoderma capsules.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Liver-protecting Drugs
48.0 %
178 46.1 % 203 48.0 % +13.94%
Anti-hepatitis B Virus Drugs
28.8 %
155 40.2 % 122 28.8 % -21.54%
Cardiovascular Drugs
8.4 %
22 5.8 % 36 8.4 % +58.14%
Anti-coronavirus Drugs
5.0 %
- - 21 5.0 % -
Digestive System Drugs
4.5 %
18 4.8 % 19 4.5 % +2.25%
Men's Health Products
2.5 %
3 0.7 % 10 2.5 % +314.68%
Other
2.2 %
6 1.6 % 9 2.2 % +56.44%
Respiratory Drugs
0.7 %
3 0.9 % 3 0.7 % -6.31%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
386 100.0 % 423 100.0 % +9.58%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 28/01/28
Director of Finance/CFO 48 25/17/25
Chairman 66 01/11/01
Chief Operating Officer 55 06/21/06
Director/Board Member 48 20/16/20
Director/Board Member 53 01/02/01
Investor Relations Contact 42 -
Corporate Officer/Principal - 04/23/04

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 56 28/01/28
Director/Board Member 54 20/11/20
Director/Board Member 53 01/02/01
Chairman 66 01/11/01
Director/Board Member 64 06/21/06
Director/Board Member 48 20/16/20
Director/Board Member 56 23/21/23
Director/Board Member 61 20/17/20
Director/Board Member 52 20/17/20
Chief Operating Officer 55 06/21/06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 159,267,000 80,116,648 ( 50.30 %) 0 50.30 %

Shareholders

NameEquities%Valuation
37,708,868 28.30 % 90 M ¥
Fujian Pingtan Aotai Technology Investment Center LP
6.022 %
8,025,000 6.022 % 19 M ¥
Western Leadbank Fund Management Co., Ltd
0.0271 %
36,100 0.0271 % 86 163 ¥
China Fund Management Co., Ltd.
0.004953 %
6,600 0.004953 % 15 753 ¥
Manulife TEDA Fund Management Co., Ltd.
0.004127 %
5,500 0.004127 % 13 127 ¥
GF Fund Management Co., Ltd.
0.003752 %
5,000 0.003752 % 11 934 ¥
China Asset Management Co., Ltd.
0.003677 %
4,900 0.003677 % 11 695 ¥
Ping An Fund Management Co., Ltd.
0.002251 %
3,000 0.002251 % 7 160 ¥
Guotai Asset Management Co., Ltd.
0.000450 %
600 0.000450 % 1 432 ¥
NameEquities%Valuation
7,920,649 30.45 % 19 M ¥
5,625,000 21.63 % 13 M ¥

Company contact information

Fujian Cosunter Pharmaceutical Co., Ltd.

Bldg16, Phase II, Innovation Park No. 7 Wulongjiang Middle Avenue

350108, Fuzhou

+

http://www.cosunter.com
address Fujian Cosunter Pharmaceutical Co., Ltd.(300436)
  1. Stock Market
  2. Equities
  3. 300436 Stock
  4. Company Fujian Cosunter Pharmaceutical Co., Ltd.